Sheneli Perera1, Anum Aslam1, Julia Stehli2, David Kaye3, Jamie Layland4, Stephen J Nicholls5, James Cameron5, Sarah Zaman6. 1. Department of Medicine, Monash University, Melbourne, Vic, Australia. 2. Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia; Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia. 3. Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia; Division of Cardiovascular, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia. 4. Department of Cardiology, Peninsula Health, Melbourne, Vic, Australia; Peninsula Clinical School, Monash University, Melbourne, Vic, Australia. 5. Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia; MonashHeart, Monash Medical Centre, Melbourne, Vic, Australia. 6. Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia; MonashHeart, Monash Medical Centre, Melbourne, Vic, Australia. Electronic address: sarah.zaman@monash.edu.
Abstract
BACKGROUND: Coronary artery disease (CAD) is the leading cause of mortality in Australian women. We identified gender differences in healthy lifestyle adherence in patients treated with percutaneous coronary intervention (PCI) for CAD. METHODS: Consecutive patients were prospectively recruited from three Australian institutions (2016-2017). The primary endpoint at 1 year follow-up was healthy lifestyle adherence defined as 3/3 of: a heart-healthy diet, being physically active and not smoking. Secondary endpoints included cardiac rehabilitation attendance, medication use and lipid levels. RESULTS: From 729 participants (n=192, 26.3% women) 56% were adherent to all three lifestyle measures with no gender difference overall. Compared to men, women were less likely to smoke (7.7% versus 12.2%, p<0.001) to be physically active (61.5% versus 78.2%; p<0.0001), attend cardiac rehabilitation (58.2% versus 66.4%; p<0.045), and take statin therapy (85.4% versus 94.7%; p<0.0001). Female gender independently predicted physical inactivity (OR 2.41, 95% CI 1.57-3.68, p<0.001). CONCLUSION: Important gender differences exist in patients treated with PCI for CAD, namely, significant lower physical activity, cardiac rehabilitation attendance and statin use in women. These all represent key targets for gender-specific secondary prevention interventions. Crown
BACKGROUND:Coronary artery disease (CAD) is the leading cause of mortality in Australian women. We identified gender differences in healthy lifestyle adherence in patients treated with percutaneous coronary intervention (PCI) for CAD. METHODS: Consecutive patients were prospectively recruited from three Australian institutions (2016-2017). The primary endpoint at 1 year follow-up was healthy lifestyle adherence defined as 3/3 of: a heart-healthy diet, being physically active and not smoking. Secondary endpoints included cardiac rehabilitation attendance, medication use and lipid levels. RESULTS: From 729 participants (n=192, 26.3% women) 56% were adherent to all three lifestyle measures with no gender difference overall. Compared to men, women were less likely to smoke (7.7% versus 12.2%, p<0.001) to be physically active (61.5% versus 78.2%; p<0.0001), attend cardiac rehabilitation (58.2% versus 66.4%; p<0.045), and take statin therapy (85.4% versus 94.7%; p<0.0001). Female gender independently predicted physical inactivity (OR 2.41, 95% CI 1.57-3.68, p<0.001). CONCLUSION: Important gender differences exist in patients treated with PCI for CAD, namely, significant lower physical activity, cardiac rehabilitation attendance and statin use in women. These all represent key targets for gender-specific secondary prevention interventions. Crown
Authors: Patrizia Steca; Roberta Adorni; Andrea Greco; Francesco Zanatta; Francesco Fattirolli; Cristina Franzelli; Cristina Giannattasio; Marco D'Addario Journal: BMC Public Health Date: 2022-01-27 Impact factor: 4.135
Authors: Leah Hernandez; Agne Laucyte-Cibulskiene; Liam J Ward; Alexandra Kautzky-Willer; Maria-Trinidad Herrero; Colleen M Norris; Valeria Raparelli; Louise Pilote; Peter Stenvinkel; Karolina Kublickiene Journal: Front Cardiovasc Med Date: 2022-08-08